Tailoring therapy for leukaemia patients

Share :
Published: 3 Dec 2016
Views: 2065
Rating:
Save
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA

Dr Sekeres speaks with ecancertv at ASH 2016 to discuss three presentations from a press conference he chaired at the conference.

For more on vadastuximab talirine, you can watch Dr Harry Erba speak with ecancer here.

From more on TKI cessation and dose reduction, you can watch interviews with Dr Francois-Xavier Mahon and Prof Mhairi Copland.

ecancer's filming at ASH 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.